Alpine Global Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,164
Closed -$22.9K 220
2023
Q1
$22.9K Sell
15,164
-18,127
-54% -$27.4K 0.01% 92
2022
Q4
$83K Buy
+33,291
New +$83K 0.03% 348